| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 148, 259-265, Copyright © 1996 by American Society for Investigative Pathology
REGULAR ARTICLES |
H Fukumoto, A Asami-Odaka, N Suzuki, H Shimada, Y Ihara and T Iwatsubo
Department of Neuropathology and Neuroscience Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.
Two distinct species of amyloid beta protein (A beta) with different C- termini, A beta 42(43) and A beta 40, are deposited in senile plaques (SP) of Alzheimer's disease (AD), with the former being far predominant. To investigate whether A beta 42(43) also predominates over A beta 40 in normal aging, we examined by immunocytochemistry the C-termini of A beta in SP in the brains of non-demented aged individuals and compared the results with those in AD. Virtually all SP were A beta 42(43)-positive; of these 12% in non-demented aged individuals and 25% in AD patients (mean of three areas examined) were also A beta 40-positive. In both the AD and non-demented groups, 2/3 of the A beta 40-positive SP were typical cored SP. These results indicate that A beta 42(43) is the predominant species deposited in SP in normal aging, and there is no qualitative difference in terms of the C- terminus of A beta in the parenchymal amyloid deposition between normal aging and AD.
This article has been cited by other articles:
![]() |
H. Fukumoto, D. L. Rosene, M. B. Moss, S. Raju, B. T. Hyman, and M. C. Irizarry {beta}-Secretase Activity Increases with Aging in Human, Monkey, and Mouse Brain Am. J. Pathol., February 1, 2004; 164(2): 719 - 725. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Parvathy, P. Davies, V. Haroutunian, D. P. Purohit, K. L. Davis, R. C. Mohs, H. Park, T. M. Moran, J. Y. Chan, and J. D. Buxbaum Correlation Between A{beta}x-40-, A{beta}x-42-, and A{beta}x-43-Containing Amyloid Plaques and Cognitive Decline Arch Neurol, December 1, 2001; 58(12): 2025 - 2031. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Takeuchi, M. C. Irizarry, K. Duff, T. C. Saido, K. Hsiao Ashe, M. Hasegawa, D. M. A. Mann, B. T. Hyman, and T. Iwatsubo Age-Related Amyloid {beta} Deposition in Transgenic Mice Overexpressing Both Alzheimer Mutant Presenilin 1 and Amyloid {beta} Precursor Protein Swedish Mutant Is Not Associated with Global Neuronal Loss Am. J. Pathol., July 1, 2000; 157(1): 331 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Munoz and H. Feldman Causes of Alzheimer's disease Can. Med. Assoc. J., January 1, 2000; 162(1): 65 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kato, A. Fukunari, Y. Sakai, and T. Nakajima Prevention of Amyloid-Like Deposition by a Selective Prolyl Endopeptidase Inhibitor, Y-29794, in Senescence-Accelerated Mouse J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 328 - 335. [Abstract] [Full Text] |
||||
![]() |
E. M. Castano, F. Prelli, C. Soto, R. Beavis, E. Matsubara, M. Shoji, and B. Frangione The length of Amyloid-beta in Hereditary Cerebral Hemorrhage with Amyloidosis, Dutch Type. IMPLICATIONS FOR THE ROLE OF AMYLOID-beta 1-42 IN ALZHEIMER'S DISEASE J. Biol. Chem., December 13, 1996; 271(50): 32185 - 32191. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. McLaurin and A. Chakrabartty Membrane Disruption by Alzheimer beta -Amyloid Peptides Mediated through Specific Binding to Either Phospholipids or Gangliosides. IMPLICATIONS FOR NEUROTOXICITY J. Biol. Chem., October 25, 1996; 271(43): 26482 - 26489. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |